Table 2. Stratification of the included... | American Society of Hematology

Table 2.

Stratification of the included patients with one unexplained pregnancy loss from the 10th week of amenorrhea, according to the principal underlying thrombophilic disorders, and effect of the two treatments on the rate of live births

Main thrombophilic disorder	With negative protein Z deficiency and negative antiprotein Z antibodies	With positive protein Z deficiency and negative antiprotein Z antibodies	With negative protein Z deficiency and positive antiprotein Z antibodies	With positive protein Z deficiency and positive antiprotein Z antibodies
Factor V Leiden mutation	26	16	20	10
Low-dose aspirin	06/13	02/08	03/10	01/05
Enoxaparin	13/13	08/08	10/10	03/05
Prothrombin G20210A mutation	30	10	14	06
Low-dose aspirin	07/15	01/05	02/07	00/03
Enoxaparin	14/15	04/05	05/07	01/03
Protein S deficiency	04	12	08	04
Low-dose aspirin	01/02	00/06	00/04	00/02
Enoxaparin	02/02	06/06	03/04	00/02
Patients: total	60	38	42	20
Low-dose aspirin	14/30	03/19	05/21	01/10
Enoxaparin	29/30	18/19	18/21	04/10

Main thrombophilic disorder	With negative protein Z deficiency and negative antiprotein Z antibodies	With positive protein Z deficiency and negative antiprotein Z antibodies	With negative protein Z deficiency and positive antiprotein Z antibodies	With positive protein Z deficiency and positive antiprotein Z antibodies
Factor V Leiden mutation	26	16	20	10
Low-dose aspirin	06/13	02/08	03/10	01/05
Enoxaparin	13/13	08/08	10/10	03/05
Prothrombin G20210A mutation	30	10	14	06
Low-dose aspirin	07/15	01/05	02/07	00/03
Enoxaparin	14/15	04/05	05/07	01/03
Protein S deficiency	04	12	08	04
Low-dose aspirin	01/02	00/06	00/04	00/02
Enoxaparin	02/02	06/06	03/04	00/02
Patients: total	60	38	42	20
Low-dose aspirin	14/30	03/19	05/21	01/10
Enoxaparin	29/30	18/19	18/21	04/10